Cue Biopharma, Inc. Gains 41.6%
Fri, Oct 04, 2024 at 07:31 PM
Cue Biopharma, Inc. (CUE:NASDAQ) jumped higher at $1.16, a gain of 41.6%. On Fri, Oct 04, 2024, CUE:NASDAQ hit a New 2-Week High of $1.16. The stock appeared on our News Catalysts scanner on Fri, Oct 04, 2024 at 11:11 AM in the 'BIOTECH' category. From Fri, Sep 20, 2024, the stock recorded 60.00% Up Days and 54.55% Green Days
About Cue Biopharma, Inc. (CUE:NASDAQ)
Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
Top 10 Gainers:
- Chanson International Holding (CHSN:NASDAQ), 387.17%
- Phoenix Motor Inc. (PEV:NASDAQ), 207.91%
- Entero Therapeutics Inc Com Par $0.0001 (New) (ENTO:NASDAQ), 73.32%
- Beneficient (BENF:NASDAQ), 58.82%
- Forward Industries, Inc. (FORD:NASDAQ), 52.41%
- Cue Biopharma, Inc. (CUE:NASDAQ), 41.6%
- Snail, Inc. (SNAL:NASDAQ), 36.42%
- Alpha Technology Group Limited (ATGL:NASDAQ), 36.11%
- UP Fintech Holding Limited (TIGR:NASDAQ), 34.82%
- Boqii Holding Limited American Depositary Shares representing Class A (BQ:NYSEMKT), 34.54%